Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Pechala's Reports
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

IGI Laboratories Inc reaffirms FY 2014 revenue guidance

Thursday, 24 Jul 2014 06:02am EDT 

IGI Laboratories Inc:Continues to expect FY 2014 revenue to increase between 40 pct and 45 pct over FY 2013.Reported revenue of $18.2 mln in FY 2013.FY 2014 revenue of $27.33 mln - Thomson Reuters I/B/E/S. 

Company Quote

-0.13 -1.66%
17 Sep 2014